Citations

Clear

3942 citation(s) found for "To, Van".

Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure
Feio‐Azevedo, Rita , Boesch, Markus , Radenkovic, Silvia , Melkebeke, Lukas Van , Smets, Lena , Wallays, Marie , Philips, Gino, Oliveira, Janaíne Prata de , Ghorbani, Mohammad , Laleman, Wim , Meersseman, Philippe , Wilmer, Alexander , Cassiman, David , Malenstein, Hannah van , Sánchez, Cristina, Aguilar, Ferrán , Nevens, Frederik , Verbeek, Jef , Denadai‐Souza, Alexandre , Lambrechts, Diether , Korf, Hannelie , Merwe, Van der , Lambrechts, Diether , Lambrechts, Diether , Lambrechts, Diether , Verbeek, Jef , Boeckx, Bram , Triantafyllou, Evangelos , Moreau, Richard , Arroyo, Vicente , Clària, Joan , Ghesquière, Bart

Mayo Clinic

Hepatology | May 18, 2024 | Volume: 81 | Issue: 2 | Pages: 509-522

10.1097/hep.0000000000000907 | PMID 38761406 Get It

Background and Aims: Acute-on-chronic liver failure (ACLF) is a complication of cirrhosis characterized by multiple organ failure and high short-term mortality. The pathophysiology of ACLF involves elevated systemic inflammation leading to organ failure, along with immune dysfunction that heightens susceptibility to bacterial infections. However, it is unclear how these aspects are associated with recovery and nonrecovery in ACLF. Approach and Results: Here, we mapped the single-cell transcriptome of circulating immune cells from patients with ACLF and acute decompensated (AD) cirrhosis and healthy individuals. We further interrogate how these findings, as well as immunometabolic and functional profiles, associate with ACLF-recovery (ACLF-R) or nonrecovery (ACLF-NR). Our analysis unveiled 2 distinct states of classical monocytes (cMons). Hereto, ACLF-R cMons were characterized by transcripts associated with immune and stress tolerance, including anti-inflammatory genes such as RETN and LGALS1. Additional metabolomic and functional validation experiments implicated an elevated oxidative phosphorylation metabolic program as well as an impaired ACLF-R cMon functionality. Interestingly, we observed a common stress-induced tolerant state, oxidative phosphorylation program, and blunted activation among lymphoid populations in patients with ACLF-R. Conversely, ACLF-NR cMon featured elevated expression of inflammatory and stress response genes such as VIM, LGALS2, and TREM1, along with blunted metabolic activity and increased functionality. Conclusions: This study identifies distinct immunometabolic cellular states that contribute to disease outcomes in patients with ACLF. Our findings provide valuable insights into the pathogenesis of ACLF, shedding light on factors driving either recovery or nonrecovery phenotypes, which may be harnessed as potential therapeutic targets in the future.
Occurrence of Nephrogenic Systemic Fibrosis with Group II Gadolinium-Based Contrast Agent in a Pediatric Oncology Patient with AKI
Scheuermann, Amanda , Hopp, Amanda , Young, Kara, Why, Scott K. Van, Hanna, Christian , Dillon, John

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 32 | Issue: 10S | Pages: 620-620

10.1681/asn.20213210s1620b Get It

ILLUMINATE-B, a Phase 3 Open-Label Study to Evaluate Lumasiran, an RNAi Therapeutic, in Young Children with Primary Hyperoxaluria Type 1 (PH1)
Michael, Mini , Cochat, Pierre , Magen, Daniella , Hoff, William van’t , Sas, David J. , Schalk, Gesa, Shasha‐Lavsky, Hadas , Bae, Kyounghwa, Seddighzadeh, Ali, Garg, Pushkal, Vaishnaw, Akshay, McGregor, Tracy L., Fujita, Kenji P. , Frishberg, Yaacov, Deschênes, Georges , Hayes, Wesley Nathan

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 515-515

10.1681/asn.20203110s1515a Get It

Peripheral Venous Pressure+Fenestration Doppler=Noninvasive Cardiac Catheterization Post-Fontan
Miranda, William R. , Bruaene, Alexander Van De , Jain, C. Charles , Van De Bruaene, Alexander

Mayo Clinic

Circulation: Heart Failure | May 14, 2024 | Volume: 17 | Issue: 5 | Pages: No page available

10.1161/circheartfailure.124.011562 | PMID 38742413 Get It

Oral Health-Related Quality of Life in Rare Disorders of Congenital Facial Weakness
Almpani, Konstantinia , Bassim, Carol W. , Ryzin, Carol Van, Engle, Elizabeth C. , Collins, Francis S. , Manoli, Irini , Lee, Janice S. , Almpani, Konstantinia , Jabs, Ethylin Wang, Engle, Elizabeth C , Collins, Francis S , Manoli, Irini , Liberton, Denise K. , Mishra, Rashmi , Webb, Bryn D. , Jabs, Ethylin W

Mayo Clinic

International Journal of Environmental Research and Public Health | May 14, 2024 | Volume: 21 | Issue: 5 | Pages: 615

10.3390/ijerph21050615 | PMID 38791829 Get It

Congenital facial weakness (CFW) encompasses a heterogenous set of rare disorders presenting with decreased facial movement from birth, secondary to impaired function of the facial musculature. The aim of the present study is to provide an analysis of subject-reported oral health-related quality of life (OHRQoL) in congenital facial weakness (CFW) disorders. Forty-four subjects with CFW and age- and sex- matched controls were enrolled in an Institutional Review Board (IRB)-approved study. Demographic data, medical and surgical history, comprehensive oral examination, and the Oral Health Impact Profile (OHIP-14) were obtained. Compared to unaffected controls, subjects with CFW had higher OHIP-14 scores overall (mean ± SD: 13.11 ± 8.11 vs. 4.46 ± 4.98, p < 0.0001) and within five of seven oral health domains, indicating decreased OHRQoL. Although subjects with Moebius syndrome (MBS) were noted to have higher OHIP-14 scores than those with Hereditary Congenital Facial Paresis (HCFP), there was no significant correlation in OHIP-14 score to age, sex, or specific diagnosis. An increase in OHIP-14 scores in subjects was detected in those who had undergone reanimation surgery. In conclusion, subjects with CFW had poorer OHRQoL compared to controls, and subjects with MBS had poorer OHRQoL than subjects with HCFP. This study provides better understanding of oral health care needs and quality of life in a CFW cohort and suggests that guidelines for dental treatment are required.
Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum
Sabbag, Avi , Aabel, Eivind W. , Castrini, Anna Isotta , Siontis, Konstantinos C. , Duthoit, Guillaume , Asirvatham, Samuel J. , Sehrawat, Ojasay, Kirkels, Feddo P. , Rav, Moshe , Peichl, Petr , Lim, H. , Martins, Raphaël P. , Font, Jonaz , Truong, Nguyen Ngoc Khoi , Estensen, Mette E , Laredo, Mikael , Duthoit, Guillaume , Kirkels, Feddo P , Beinart, Roy , Peichl, Petr , Sohns, Christian , Haugaa, Kristina , Asirvatham, Samuel J , Martins, Raphael , Aabel, Eivind W , Sabbag, Avi , Nizard, J. , Rosendael, Philippe J. van , Beinart, Roy , Haugaa, Kristina H.

Mayo Clinic

European Heart Journal | May 14, 2024 | Volume: 45 | Issue: 20 | Pages: 1831-1839

10.1093/eurheartj/ehae224 | PMID 38740526 Get It

Abstract Background and Aims Arrhythmic mitral valve prolapse (AMVP) is linked to life-threatening ventricular arrhythmias (VAs), and young women are considered at high risk. Cases of AMVP in women with malignant VA during pregnancy have emerged, but the arrhythmic risk during pregnancy is unknown. The authors aimed to describe features of women with high-risk AMVP who developed malignant VA during the perinatal period and to assess if pregnancy and the postpartum period were associated with a higher risk of malignant VA. Methods This retrospective international multi-centre case series included high-risk women with AMVP who experienced malignant VA and at least one pregnancy. Malignant VA included ventricular fibrillation, sustained ventricular tachycardia, or appropriate shock from an implantable cardioverter defibrillator. The authors compared the incidence of malignant VA in non-pregnant periods and perinatal period; the latter defined as occurring during pregnancy and within 6 months after delivery. Results The authors included 18 women with AMVP from 11 centres. During 7.5 (interquartile range 5.8–16.6) years of follow-up, 37 malignant VAs occurred, of which 18 were pregnancy related occurring in 13 (72%) unique patients. Pregnancy and 6 months after delivery showed increased incidence rate of malignant VA compared to the non-pregnancy period (univariate incidence rate ratio 2.66, 95% confidence interval 1.23–5.76). Conclusions The perinatal period could impose increased risk of malignant VA in women with high-risk AMVP. The data may provide general guidance for pre-conception counselling and for nuanced shared decision-making between patients and clinicians.
27. The Fate Of The Frozen Bone Flap: Quantitative Assessment Of Bone Flap Resorption Following Delayed Autologous Cranioplasty
Cherukuri, Sai , Zheng, Eugene, Emanuels, Andrew F., Bite, Uldis, Emanuels, Andrew, Gompel, Jamie J. Van , Morris, Jonathan M. , Mardini, Samir , Gibreel, Waleed

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 10, 2024 | Volume: 12 | Issue: S5 | Pages: 18-19

10.1097/01.gox.0001018124.22700.84 Get It

European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency
Beuschlein, Felix , Else, Tobias , Hamidi, Oksana , Hulsteijn, Leonie T. van , Karavitaki, Niki , Prete, Alessandro , Vaidya, Anand , Yedinak, Christine, Dekkers, Olaf M, Bancos, Irina , Hamidi, Oksana , van Hulsteijn, Leonie , Vaidya, Anand , Karavitaki, Niki , Prete, Alessandro , Beuschlein, Felix , Bancos, Irina , Hahner, Stefanie , Husebye, Eystein Sverre , Dekkers, Olaf M.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | May 9, 2024 | Volume: 109 | Issue: 7 | Pages: 1657-1683

10.1210/clinem/dgae250 | PMID 38724043 Get It

Abstract Glucocorticoids are widely prescribed as anti-inflammatory and immunosuppressive agents. This results in at least 1% of the population using chronic glucocorticoid therapy, being at risk for glucocorticoid-induced adrenal insufficiency. This risk is dependent on the dose, duration and potency of the glucocorticoid, route of administration, and individual susceptibility. Once glucocorticoid-induced adrenal insufficiency develops or is suspected, it necessitates careful education and management of affected patients. Tapering glucocorticoids can be challenging when symptoms of glucocorticoid withdrawal develop, which overlap with those of adrenal insufficiency. In general, tapering of glucocorticoids can be more rapidly within a supraphysiological range, followed by a slower taper when on physiological glucocorticoid dosing. The degree and persistence of HPA axis suppression after cessation of glucocorticoid therapy are dependent on overall exposure and recovery of adrenal function varies greatly amongst individuals. This first European Society of Endocrinology/Endocrine Society joint clinical practice guideline provides guidance on this clinically relevant condition to aid clinicians involved in the care of patients on chronic glucocorticoid therapy.
Exposure to hyperoxemia and mortality in cardiac intensive care unit patients
Alviar, Carlos L. , Metkus, Thomas S. , Miller, P. Elliott , Jentzer, Jacob C. , Diepen, Sean van , Kashani, Kianoush

Mayo Clinic

European Heart Journal: Acute Cardiovascular Care | May 9, 2024 | Volume: 13 | Issue: Supplement_1 | Pages: No page available

10.1093/ehjacc/zuae036.138 Get It

Abstract Funding Acknowledgements None. Background Hyperoxemia (a high PaO2, i.e. &gt;200-300 mmHg) has been associated with adverse outcomes in general critical care settings as well as in acute cardiovascular care conditions. The association between hyperoxemia and mortality has not been characterized in the heterogeneous population admitted to the cardiac intensive care unit (CICU). We aimed to examine the association between hyperoxemia on CICU admission with in-hospital mortality. Methods We retrospectively analyzed Mayo Clinic CICU patients from January 2007 to April 2018. PaO2 closest on admission was analyzed as a continuous variable (per 100 mmHg) and categorized as: 60-100 mmHg (51.9%), 101-150 mmHg (28.6%), 151-200 mmHg (10.6%), 201-300 mmHg (6.4%), and &gt;300 mmHg (2.5%). Those without PaO2 on admission and those with hypoxemia were excluded. The primary outcome was all-cause in-hospital mortality evaluated using logistic regression, after adjusting for age, Charlson Comorbidity Index, M-CARS, and use of IMV and NIPPV. Results A total of 3,368 patients were included (median 70.3 years, 39.4% women). Admission diagnoses included ACS (37.0%, with 19.8% STEMI), HF (67.8%), shock (33.0%) and cardiac arrest (25.3%). Median admission PaO2 was 99 (IQR 78, 136) mmHg, with no difference in median PaO2 between hospital survivors and inpatient deaths (99 versus 98, p = 0.38). A J-shaped relationship was observed between admission PaO2 and in-hospital mortality (Figure A), with slightly higher mortality below 100 mmHg and incrementally higher mortality above this threshold (esp. at &gt;200 mmHg). The incremental association between higher PaO2 and mortality (adjusted OR 1.17 per 100 mmHg higher, 95% CI 1.01-1.34, P = 0.03) was focused in the highest PaO2 group (i.e., &gt;300 mmHg; Figure B). Conclusion Hyperoxia (esp. PaO2 &gt;300 mmHg) on CICU admission is associated with increased in-hospital mortality, demonstrating a J-shaped association with an inflection point of lowest mortality around 100 mmHg. Further studies are warranted to assess if specific oxygen targets influence outcomes in critically ill cardiac patients.
Volumetric Analysis of a Novel Chimeric Gracilis and Profunda Artery Perforator Flap
Spronsen, Nicole Van , Plonkowski, Alexander T. , Jokerst, Clint , Shrout, Max A., Reece, Edward, Casey, William J., Rebecca, Alanna M. , Van Spronsen, Nicole R, Reece, Edward M., Hammond, Jacob B. , Flug, Jonathan A.

Mayo Clinic

Journal of Reconstructive Microsurgery | May 6, 2024 | Volume: 41 | Issue: 01 | Pages: 063-067

10.1055/a-2320-5489 | PMID 38710225 Get It

Abstract Background The presence of a chimeric gracilis and profunda artery perforator (PAP) flap with a common arterial pedicle has been demonstrated on computed tomography angiography in up to 59% of patients and confirmed in a cadaveric model. Already utilized for head and neck reconstruction by Heredero et al, this novel flap could provide more volume than either flap alone which is advantageous, particularly in patients with sizable defects. The purpose of this study was to determine the average tissue volume that can be utilized from this chimeric flap. Methods CT Angiogram imaging studies exhibiting chimeric flap anatomy were reviewed over a 7-year period at a single institution utilizing Visage Version 7.1, a radiology picture archiving and communication system. This software was used to trace the flap pedicles and to capture estimated soft tissue volumes of each respective flap. Results A total of 31 patients, consisting of 52 lower extremity gracilis and PAP chimeric flaps, underwent tissue volume analysis. The average total volume of soft tissue supplied by the gracilis flap was found to be 70.21 cm3 (standard deviation [SD] = 26.99). The average volume of the PAP flap was 31.73 cm3 (SD = 26.12). The average total volume captured by the chimeric gracilis and PAP flap was 101.94 cm3 (SD = 62.40). Conclusion The potential soft tissue volume that can be harvested from a chimeric gracilis and PAP flap is significantly greater than solitary gracilis or PAP flaps. This chimeric flap may serve as a viable and advantageous reconstructive option for patients requiring large volume soft tissue coverage, particularly if other sizable options are not available.